Your activity: 14 p.v.

Medications associated with weight gain and alternatives

Medications associated with weight gain and alternatives
Category Drug class Weight gain Alternatives
Psychiatric agents Antipsychotic Clozapine, risperidone, olanzapine, quetiapine, haloperidol, perphenazine Ziprasidone, aripiprazole
Antidepressants/mood stabilizers: tricyclic antidepressants Amytriptyline, doxepin, imipramine, nortriptyline, trimipramine, mirtazapine Bupropion*, nefazodone, fluoxetine (short term), sertraline (<1 year)
Antidepressants/mood stabilizers: SSRIs Fluoxetine, sertraline, paroxetine, fluvoxamine
Antidepressants/mood stabilizers: MAOIs Phenylzine, tranylcypromine
Lithium
Neurologic agents Antiseizure medications Carbamazepine, gabapentin, valproate Lamotrigine, topiramate*, zonisamide*
Endocrinologic agents Diabetes drugs Insulin (weight gain differs with type and regimen used), sulfonylureas, thiazolidinediones, sitagliptin, metiglinide Metformin*, acarbose*, miglitol*, pramlintide*, edenatide*, liraglutide*
Gynecologic agents Oral contraceptives Progestational steroids, hormonal contraceptives containing progestational steroids Barrier methods, IUDs
Endometriosis treatment Depot leuprolide acetate Surgical methods
Cardiologic agents Antihypertensives alpha-blocker, beta-blocker ACE inhibitors, calcium channel blockers, angiotensin-2 receptor antagonists
Infectious disease agents Antiretroviral therapy Protease inhibitors
General Steroid hormones Corticosteroids, progestational steroids NSAIDs
Antihistamines/anticholinergics Diphenhydramine, doxepin, cyproheptadine Decongestants, steroid inhalers
* Weight-neutral or promotes weight loss.
¶ The data supporting the effects of these medications on weight gain are low quality or conflicting.
Information from: Apovian CM, Aronne LJ, Bessesen DH, et al. Pharmacological management of obesity: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2015; 100:342.
Graphic 132587 Version 2.0